Biograil

Biograil is a pre-clinical stage pharmaceutical company based in Roskilde, Denmark, developing its proprietary BIONDD technology to transform injectable biologics into convenient oral capsules. The BIONDD platform uses a small, easy-to-swallow capsule that dissolves in the stomach and releases a spring-loaded device which attaches to the stomach wall to deliver medication directly into tissue for systemic distribution. After drug delivery, the bio-compostable device passes safely through the GI tract. This breakthrough approach delivers comparable bioavailability to injections while eliminating the need for needles, addressing both patient convenience and treatment compliance. Biograil has established strategic partnerships with leading pharmaceutical companies including CSL, and holds a robust patent portfolio with verified manufacturing technology. The platform has broad applicability across multiple biologic therapies including GLP-1 agonists, monoclonal antibodies, and other injectable drug classes.